NTRK alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pfaff, Elke (VerfasserIn) , Adam de Beaumais, Tiphaine (VerfasserIn) , Marchais, Antonin (VerfasserIn) , Tilburg, Cornelis M. van (VerfasserIn) , Blattner-Johnson, Mirjam (VerfasserIn) , Dirksen, Uta (VerfasserIn) , Øra, Ingrid (VerfasserIn) , Geoerger, Birgit (VerfasserIn) , Schleiermacher, Gudrun (VerfasserIn) , Pfister, Stefan (VerfasserIn) , Witt, Olaf (VerfasserIn) , Jones, David T. W. (VerfasserIn) , Vassal, Gilles (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: February 26, 2021
In: JCO precision oncology
Year: 2021, Jahrgang: 5, Pages: 450-454
ISSN:2473-4284
DOI:10.1200/PO.20.00417
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/PO.20.00417
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/PO.20.00417
Volltext
Verfasserangaben:Elke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, Cornelis M. van Tilburg, Mirjam Blattner-Johnson, Uta Dirksen, Ingrid Øra, Birgit Geoerger, Gudrun Schleiermacher, Stefan M. Pfister, Olaf Witt, David T.W. Jones, Gilles Vassal

MARC

LEADER 00000caa a2200000 c 4500
001 1759037737
003 DE-627
005 20250211102016.0
007 cr uuu---uuuuu
008 210527s2021 xx |||||o 00| ||eng c
024 7 |a 10.1200/PO.20.00417  |2 doi 
035 |a (DE-627)1759037737 
035 |a (DE-599)KXP1759037737 
035 |a (OCoLC)1341413955 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pfaff, Elke  |d 1985-  |e VerfasserIn  |0 (DE-588)1037262174  |0 (DE-627)755739728  |0 (DE-576)39127614X  |4 aut 
245 1 0 |a NTRK alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets  |c Elke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, Cornelis M. van Tilburg, Mirjam Blattner-Johnson, Uta Dirksen, Ingrid Øra, Birgit Geoerger, Gudrun Schleiermacher, Stefan M. Pfister, Olaf Witt, David T.W. Jones, Gilles Vassal 
264 1 |c February 26, 2021 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.05.2021 
700 1 |a Adam de Beaumais, Tiphaine  |e VerfasserIn  |4 aut 
700 1 |a Marchais, Antonin  |e VerfasserIn  |4 aut 
700 1 |a Tilburg, Cornelis M. van  |e VerfasserIn  |0 (DE-588)1144664527  |0 (DE-627)1004962355  |0 (DE-576)495479519  |4 aut 
700 1 |a Blattner-Johnson, Mirjam  |e VerfasserIn  |0 (DE-588)125143231X  |0 (DE-627)178908539X  |4 aut 
700 1 |a Dirksen, Uta  |e VerfasserIn  |4 aut 
700 1 |a Øra, Ingrid  |e VerfasserIn  |4 aut 
700 1 |a Geoerger, Birgit  |e VerfasserIn  |4 aut 
700 1 |a Schleiermacher, Gudrun  |e VerfasserIn  |0 (DE-588)1355831059  |0 (DE-627)1916773176  |4 aut 
700 1 |a Pfister, Stefan  |d 1974-  |e VerfasserIn  |0 (DE-588)123850215  |0 (DE-627)706450930  |0 (DE-576)293908400  |4 aut 
700 1 |a Witt, Olaf  |d 1965-  |e VerfasserIn  |0 (DE-588)17275030X  |0 (DE-627)697681750  |0 (DE-576)133607410  |4 aut 
700 1 |a Jones, David T. W.  |e VerfasserIn  |0 (DE-588)1058669672  |0 (DE-627)79739334X  |0 (DE-576)414823583  |4 aut 
700 1 |a Vassal, Gilles  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t JCO precision oncology  |d Alexandria, VA : American Society of Clinical Oncology, 2017  |g 5(2021), Seite 450-454  |h Online-Ressource  |w (DE-627)1067396667  |w (DE-600)2964799-X  |w (DE-576)518266486  |x 2473-4284  |7 nnas  |a NTRK alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets 
773 1 8 |g volume:5  |g year:2021  |g pages:450-454  |g extent:5  |a NTRK alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets 
856 4 0 |u https://doi.org/10.1200/PO.20.00417  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://ascopubs.org/doi/10.1200/PO.20.00417  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210527 
993 |a Editorial 
994 |a 2021 
998 |g 1058669672  |a Jones, David T. W.  |m 1058669672:Jones, David T. W.  |d 50000  |e 50000PJ1058669672  |k 0/50000/  |p 12 
998 |g 17275030X  |a Witt, Olaf  |m 17275030X:Witt, Olaf  |d 910000  |d 910500  |d 50000  |e 910000PW17275030X  |e 910500PW17275030X  |e 50000PW17275030X  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 11 
998 |g 123850215  |a Pfister, Stefan  |m 123850215:Pfister, Stefan  |d 910000  |d 910500  |e 910000PP123850215  |e 910500PP123850215  |k 0/910000/  |k 1/910000/910500/  |p 10 
998 |g 1144664527  |a Tilburg, Cornelis M. van  |m 1144664527:Tilburg, Cornelis M. van  |d 910000  |d 910500  |e 910000PT1144664527  |e 910500PT1144664527  |k 0/910000/  |k 1/910000/910500/  |p 4 
998 |g 1037262174  |a Pfaff, Elke  |m 1037262174:Pfaff, Elke  |d 910000  |d 910500  |e 910000PP1037262174  |e 910500PP1037262174  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1759037737  |e 3931756467 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1759037737","id":{"eki":["1759037737"],"doi":["10.1200/PO.20.00417"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Elke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, Cornelis M. van Tilburg, Mirjam Blattner-Johnson, Uta Dirksen, Ingrid Øra, Birgit Geoerger, Gudrun Schleiermacher, Stefan M. Pfister, Olaf Witt, David T.W. Jones, Gilles Vassal"]},"origin":[{"dateIssuedDisp":"February 26, 2021","dateIssuedKey":"2021"}],"note":["Gesehen am 27.05.2021"],"language":["eng"],"person":[{"display":"Pfaff, Elke","role":"aut","family":"Pfaff","given":"Elke"},{"family":"Adam de Beaumais","role":"aut","display":"Adam de Beaumais, Tiphaine","given":"Tiphaine"},{"given":"Antonin","display":"Marchais, Antonin","role":"aut","family":"Marchais"},{"display":"Tilburg, Cornelis M. van","family":"Tilburg","role":"aut","given":"Cornelis M. van"},{"given":"Mirjam","role":"aut","family":"Blattner-Johnson","display":"Blattner-Johnson, Mirjam"},{"given":"Uta","display":"Dirksen, Uta","family":"Dirksen","role":"aut"},{"given":"Ingrid","display":"Øra, Ingrid","role":"aut","family":"Øra"},{"given":"Birgit","display":"Geoerger, Birgit","role":"aut","family":"Geoerger"},{"display":"Schleiermacher, Gudrun","family":"Schleiermacher","role":"aut","given":"Gudrun"},{"family":"Pfister","role":"aut","display":"Pfister, Stefan","given":"Stefan"},{"given":"Olaf","family":"Witt","role":"aut","display":"Witt, Olaf"},{"family":"Jones","role":"aut","display":"Jones, David T. W.","given":"David T. W."},{"given":"Gilles","display":"Vassal, Gilles","role":"aut","family":"Vassal"}],"relHost":[{"part":{"volume":"5","text":"5(2021), Seite 450-454","year":"2021","pages":"450-454","extent":"5"},"title":[{"subtitle":"an American Society of Clinical Oncology journal","title_sort":"JCO precision oncology","title":"JCO precision oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"American Society of Clinical Oncology","dateIssuedKey":"2017","publisherPlace":"Alexandria, VA","dateIssuedDisp":"2017-"}],"disp":"NTRK alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targetsJCO precision oncology","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"1067396667","id":{"zdb":["2964799-X"],"eki":["1067396667"],"issn":["2473-4284"]},"language":["eng"],"titleAlt":[{"title":"JCO PO"}],"pubHistory":["Volume 1 (2017)-"],"note":["Gesehen am 06.07.21"]}],"physDesc":[{"extent":"5 S."}],"title":[{"title":"NTRK alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets","title_sort":"NTRK alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets"}]} 
SRT |a PFAFFELKEANTRKALTERA2620